OTC: YBGJ
Yubo International Biotech LtdCIK 0000895464 · SIC 3845 · Electromedical Equipment
Micro
Revenue $12K
Assets $651K
as of Nov 12, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (AKAM 10-Q) is open in full — no account needed.
10-Q
Filed Nov 10, 2026
· Period ending Sep 30, 2026
Summary not yet generated.
10-Q
Filed Aug 14, 2026
· Period ending Jun 30, 2026
Summary not yet generated.
Partner
Trade YBGJ commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
10-K
Filed Mar 31, 2026
· Period ending Dec 31, 2025
Summary not yet generated.
8-K
Filed Jan 16, 2026
· Period ending Jan 13, 2026
Summary not yet generated.
8-K
Filed Jul 25, 2025
· Period ending Jul 23, 2025
Summary not yet generated.
10-K
Filed Mar 31, 2025
· Period ending Dec 31, 2024
Summary not yet generated.
8-K
Filed Jan 6, 2025
· Period ending Dec 26, 2024
Summary not yet generated.
424B3
Filed Nov 16, 2022
Summary not yet generated.
424B3
Filed Aug 15, 2022
Summary not yet generated.
424B3
Filed Aug 1, 2022
Summary not yet generated.
S-1/A
Filed Jul 21, 2022
Summary not yet generated.
S-1/A
Filed Jul 8, 2022
Summary not yet generated.
S-1/A
Filed Jun 10, 2022
Summary not yet generated.
S-1
Filed May 6, 2021
Summary not yet generated.
10-Q/A
Filed Jan 18, 2013
· Period ending Nov 30, 2012
Summary not yet generated.
Latest financial statements
From 10-Q filed Nov 10, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations and Comprehensive Income (Loss)
| Description | Three months ended September 30, 2026 (unaudited) | Three months ended September 30, 2025 (unaudited) | Nine months ended September 30, 2026 (unaudited) | Nine months ended September 30, 2025 (unaudited) |
|---|---|---|---|---|
| Revenue | ||||
| Sales of products and services | - | - | - | - |
| Cost of goods and services sold | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating expenses: | ||||
| Employee compensation | 163,649 | 192,869 | 520,930 | 582,530 |
| Occupancy | 28,707 | 46,920 | 85,507 | 146,366 |
| Depreciation and amortization of property and equipment | 650 | 41,893 | 27,188 | 124,900 |
| Amortization of intangible assets | 1,772 | 1,694 | 5,260 | 8,454 |
| Other operating expenses | 8,610 | 26,758 | 92,637 | 39,978 |
| Total Operating Expenses | 203,388 | 310,134 | 731,522 | 902,228 |
| Income (loss) from operations | (203,388) | (310,134) | (731,522) | (902,228) |
| Other Income (Expenses) | ||||
| Other income (expenses), net | (338) | (18) | (35,951) | (60) |
| Total Other Income (Expenses) | (338) | (18) | (35,951) | (60) |
| Loss before Provision for Income Tax | (203,726) | (310,152) | (767,473) | (902,288) |
| Provision for Income Tax | - | - | - | - |
| Net loss | (203,726) | (310,152) | (767,473) | (902,288) |
| Net loss attributable to non-controlling interest | (15,350) | (33,381) | (58,540) | (84,458) |
| Net loss attributable to common stockholders | (188,376) | (276,771) | (708,933) | (817,830) |
| Net loss per share basic and diluted | - | - | - | (0.01) |
| Weighted average common shares outstanding basic and diluted | 170,420,790 | 147,870,790 | 170,420,790 | 129,273,537 |
| Comprehensive income (loss) | ||||
| Net loss to the Company | (188,376) | (276,771) | (708,933) | (817,830) |
| Net loss to non-controlling interests | (15,350) | (33,381) | (58,540) | (84,458) |
| Foreign currency translation adjustment to the Company | (38,983) | (40,779) | (186,360) | 49,406 |
| Foreign currency translation adjustment to non-controlling interests | - | 75,635 | - | 18,467 |
| Total comprehensive income (loss) | (242,709) | (275,296) | (953,833) | (834,415) |
Consolidated Balance Sheets
| Description | September 30, 2026 (Unaudited) | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash | 9,465 | 8,062 |
| Receivables | 123,473 | 138,043 |
| Prepaid expenses | 123,385 | 209,316 |
| Inventory | 22,410 | 24,034 |
| Due from related parties | 300,619 | 288,057 |
| Total Current Assets | 579,352 | 667,512 |
| Property and equipment, net | 17,125 | 43,030 |
| Intangible assets, net | 38,540 | 42,080 |
| Operating lease right of use asset | - | 78,783 |
| Lease security deposit | 16,374 | 15,690 |
| Total Assets | 651,391 | 847,094 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued expenses (including accounts payable and accrued expenses of VIE without recourse to the Company of $1,349,598 and $1,008,758 as of September 30, 2026 and December 31, 2025, respectively) | 1,403,836 | 1,060,730 |
| Advances from prospective customers (including advances from prospective customers of VIE without recourse to the Company of $467,713 and $440,344 as of September 30, 2026 and December 31, 2025, respectively) | 467,713 | 440,344 |
| Due to related parties (including due to related parties of VIE without recourse to the Company of $1,527,807 and $1,061,372 as of September 30, 2026 and December 31, 2025, respectively) | 1,677,878 | 1,211,440 |
| Operating lease liabilities current (including operating lease liabilities – current of VIE without recourse to the Company of 0 and $78,783 as of September 30, 2026 and December 31, 2025, respectively) | - | 78,783 |
| Total Current Liabilities | 3,549,427 | 2,791,297 |
| Non-current liabilities | ||
| Operating lease liabilities non-current (including operating lease liabilities – non-current of VIE without recourse to the Company of 0 at September 30, 2026 and December 31, 2025) | - | - |
| Total Liabilities | 3,549,427 | 2,791,297 |
| Commitments and contingencies | - | - |
| Shareholders' Deficit: | ||
| Preferred stock, par value $0.01 per share, 5,000,000 shares authorized, none issued | - | - |
| Common stock, Class A par value $0.001 per share; authorized 1,000,000,000 shares, 170,416,343 issued and outstanding at September 30, 2026 and December 31, 2025. | 170,416 | 170,416 |
| Common stock, Class B, par value $0.001 per share, 3,750,000 shares authorized, 4,447 shares issued and outstanding at September 30, 2026 and December 31, 2025. | 4 | 4 |
| Additional Paid in Capital | 5,468,883 | 5,468,883 |
| Accumulated deficit | (8,448,993) | (7,740,059) |
| Accumulated other comprehensive income (loss) | (40,260) | 146,100 |
| Total deficit attributable to common shareholders | (2,849,950) | (1,954,657) |
| Non-controlling interests | (48,086) | 10,454 |
| Total Deficit | (2,898,036) | (1,944,203) |
| Total Liabilities and Shareholders' Equity | 651,391 | 847,094 |
Consolidated Statements of Cash Flows
| Description | Nine months ended September 30, 2026 (unaudited) | Nine months ended September 30, 2025 (unaudited) |
|---|---|---|
| Cash flows from operating activities: | ||
| Net loss | (767,473) | (902,288) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 32,448 | 133,354 |
| Bad debt of prepaid expenses | 29,050 | - |
| Changes in operating assets and liabilities: | ||
| Receivables | 14,571 | 50,697 |
| Prepaid expense | 56,880 | (5,636) |
| Lease security deposit | - | 79,722 |
| Accounts payable and accrued expenses | 343,106 | (80,636) |
| Advances from prospective customers | - | 10,737 |
| Net cash used in operating activities | (291,418) | (714,050) |
| Cash flows from investing activities: | ||
| Proceeds for sale of Equipment | - | 79,904 |
| Net cash provided in investing activities | - | 79,904 |
| Cash flows from financing activities: | ||
| Advances from related parties (net) | 303,213 | 473,919 |
| Net cash provided by financing activities | 303,213 | 473,919 |
| Effect of exchange rate changes | (10,392) | 164,138 |
| Net increase (decrease) in cash | 1,403 | 3,911 |
| Cash at beginning of period | 8,062 | 7,015 |
| Cash at end of period | 9,465 | 10,926 |
| Supplemental Cash Flow Information: | ||
| Income taxes paid | - | - |
| Interest paid | - | - |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗